lobbying_activities: 754554
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 754554 | 012d2d64-f4f0-479e-9268-c5fed323abc3 | Q1 | BALCH & BINGHAM, LLP | 5197 | VAXIN PHARMACEUTICALS INC | 2009 | first_quarter | MED | Funding for Immunocontraceptive vaccines through Department of Interior, Agriculture or Transportation Appropriations bills; in ovo vaccination by recombinant adenovirus vectors through Department of Agriculture or Homeland Security Appropriations bills; non-invasive vectored vaccine research through Department of Defense Authorization or Defense Appropriations bills. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2009-04-16T17:29:24-04:00 |